Works by Chen, Xiaoyong


Results: 210
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
    By:
    • Zhao, Ke;
    • Lin, Ren;
    • Fan, Zhiping;
    • Chen, Xiaoyong;
    • Wang, Yu;
    • Huang, Fen;
    • Xu, Na;
    • Zhang, Xi;
    • Zhang, Xin;
    • Xuan, Li;
    • Wang, Shunqing;
    • Lin, Dongjun;
    • Deng, Lan;
    • Nie, Danian;
    • Weng, Jianyu;
    • Li, Yonghua;
    • Zhang, Xiaohui;
    • Li, Yuhua;
    • Xiang, A. P.;
    • Liu, Qifa
    Publication type:
    Article
    23

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
    By:
    • Zhao, Ke;
    • Lin, Ren;
    • Fan, Zhiping;
    • Chen, Xiaoyong;
    • Wang, Yu;
    • Huang, Fen;
    • Xu, Na;
    • Zhang, Xi;
    • Zhang, Xin;
    • Xuan, Li;
    • Wang, Shunqing;
    • Lin, Dongjun;
    • Deng, Lan;
    • Nie, Danian;
    • Weng, Jianyu;
    • Li, Yonghua;
    • Zhang, Xiaohui;
    • Li, Yuhua;
    • Xiang, A. P.;
    • Liu, Qifa
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50